A Study of Cytisinicline for Vaping Cessation in Adult Smokers
Trial details
- Registry ID
- NCT05431387
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as cytisine
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study of Cytisinicline for Vaping Cessation in Adult SmokersNCT05431387 | Achieve Life Sciences | Phase 2 | Completed | 2023-02-28Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |